Aurisco Pharmaceutical Co.,Ltd.

¥18.60As of Sun 8 Nov 2026, 12:00 UTC
SSE:605116Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 2.98%
Div yield 1.83%
ROE 11.99%
Biotechnology
Beta (5Y) (0.10)
PE TTM 24.11
TSR TTM (18.64%)
Mkt cap ¥7.503B
ROIC 11.90%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
1.88%
(75.04%)
Hold 6|7|8|9|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.30
0.29
0.28
0.31
21.73%
9.40%
(0.75%)
(0.82%)
Revenue¥M
428.4
444.4
445.0
470.5
11.76%
13.23%
12.83%
15.08%
Peers (US$1.125B)
Cap (US$)
PE
1.128B
50.13x
1.109B
18.76x
1.124B
34.63x
Capital
TTM
5Y
10Y
Leveragex
1.536
1.780
1.635
EBIT/Intx
0.120
0.201
0.200
Own earn%
25.14
4.90
(10.66)
Sh yield%
28.67
36.17
38.37
Owners
Insiders/Inst%
3.20
36.85
Short interest%
1.27
SBC / revenue%
1.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
13–17
$1 testx
−0.1
Incr. ROIC%
5